Sarah P. Thayer, M.D., Ph.D. / Associate Professor of Surgery; W. Gerald Austen Scholar in Academic Surgery; Director, Pancreatic Biology Laboratory / Massachusetts General Hospital

The capture, growth and genetic analysis of CTC in PDAC: What can it tell us about this disease?

CTC captured by ScreenCell devices were detected in patients with resectable PDAC.  These CTC are capable of in-vitro growth confirming tumorigenicity.  Selective deep sequencing demonstrated the feasibility of identifying mutations present in the primary tumor and their corresponding CTC.

Cambridge Healthtech Institute’s Third Annual Circulating Tumor Cells

Expediting Clinical Use

Part of the Twentieth Annual Molecular Medicine Tri-Conference
February 13-15, 2013 | Moscone North Convention Center | San Francisco, CA